Human Phenotype Ontology 
Grandparent Node:
expand
Abnormality of blood and blood-forming tissues (HP:0001871)help
Parent Node:
expand
Abnormal bleeding (HP:0001892)help
..Starting node
..expand
Prolonged bleeding time (HP:0003010)help
Term ID: 3010
Name: Prolonged bleeding time
Synonym: Increased bleeding time; Prolonged bleeding time
Definition: Prolongation of the time taken for a standardized skin cut of fixed depth and length to stop bleeding.
Comments:
Reference: HP:0003010
Genes and Diseases:
 
       Child Nodes:

 Sister Nodes: 
..expandAbnormal onset of bleeding (HP:0040231) help
..expandAbnormal umbilical stump bleeding (HP:0011884) help
..expandBleeding requiring red cell transfusion (HP:0011888) help
..expandBleeding with minor or no trauma (HP:0011889) help
..expandCephalohematoma (HP:0012541) help
..expandEpistaxis (HP:0000421) help
..expandExcessive bleeding after a venipuncture (HP:0030139) help
..expandExcessive bleeding from superficial cuts (HP:0030138) help
..expandGingival bleeding (HP:0000225) help
..expandInternal hemorrhage (HP:0011029) help
..expandMenorrhagia (HP:0000132) help
..expandOral cavity bleeding (HP:0030140) help
..expandPersistent bleeding after trauma (HP:0001934) help
..expandProlonged bleeding following procedure (HP:0011890) help
..expandSubcutaneous hemorrhage (HP:0001933) help
InputHPO IDHPO termDistanceGeneGene id entrezHGNC IDDiseaseIdDiseaseNameFrequencyOnsetHGMD variantsClinVar variants
 
HPO disease - gene - phenotype typical associations:
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0003010HP:0003010Prolonged bleeding time0ADAMTS2 CL E G H9509218ORPHA:1901Dermatosparaxis Ehlers-Danlos syndromeHP:0040281 - Very frequent165
HP:0003010HP:0003010Prolonged bleeding time0ADAMTSL2 CL E G H971914631ORPHA:1901Dermatosparaxis Ehlers-Danlos syndromeHP:0040281 - Very frequent72
HP:0003010HP:0003010Prolonged bleeding time0AGGF1 CL E G H5510924684ORPHA:90308Klippel-Trénaunay syndromeHP:0040283 - Occasional1
HP:0003010HP:0003010Prolonged bleeding time0AP3B1 CL E G H8546566OMIM:608233Hermansky-Pudlak syndrome 283
HP:0003010HP:0003010Prolonged bleeding time0BMS1 CL E G H979023505ORPHA:1114Aplasia cutis congenitaHP:0040283 - Occasional1
HP:0003010HP:0003010Prolonged bleeding time0CALR CL E G H8111455ORPHA:3318Essential thrombocythemiaHP:0040281 - Very frequent1
HP:0003010HP:0003010Prolonged bleeding time0CD36 CL E G H9481663OMIM:608404Platelet glycoprotein IV deficiency.53
HP:0003010HP:0003010Prolonged bleeding time0COL1A1 CL E G H12772197ORPHA:287Classical Ehlers-Danlos syndromeHP:0040283 - Occasional373
HP:0003010HP:0003010Prolonged bleeding time0COL5A1 CL E G H12892209ORPHA:287Classical Ehlers-Danlos syndromeHP:0040283 - Occasional660
HP:0003010HP:0003010Prolonged bleeding time0COL5A2 CL E G H12902210ORPHA:287Classical Ehlers-Danlos syndromeHP:0040283 - Occasional325
HP:0003010HP:0003010Prolonged bleeding time0CREB3L1 CL E G H9099318856OMIM:616229Osteogenesis imperfecta, type XVI4
HP:0003010HP:0003010Prolonged bleeding time0DLL4 CL E G H545672910ORPHA:1114Aplasia cutis congenitaHP:0040283 - Occasional9
HP:0003010HP:0003010Prolonged bleeding time0F2 CL E G H21473535OMIM:613679Congenital prothrombin deficiency.44
HP:0003010HP:0003010Prolonged bleeding time0F5 CL E G H21533542OMIM:227400Factor V deficiency.159
HP:0003010HP:0003010Prolonged bleeding time0GATA1 CL E G H26234170OMIM:314050Thrombocytopenia with beta-thalassemia, X-linked.29
HP:0003010HP:0003010Prolonged bleeding time0GATA2 CL E G H26244171ORPHA:3226Deafness-lymphedema-leukemia syndromeHP:0040281 - Very frequent137
HP:0003010HP:0003010Prolonged bleeding time0GFI1B CL E G H83284238OMIM:187900Bleeding disorder, platelet-type, 17.3
HP:0003010HP:0003010Prolonged bleeding time0GP1BA CL E G H28114439OMIM:231200BERNARD-SOULIER SYNDROME; BSS23
HP:0003010HP:0003010Prolonged bleeding time0GP1BA CL E G H28114439OMIM:177820Pseudo-Von willebrand disease.23
HP:0003010HP:0003010Prolonged bleeding time0GP1BB CL E G H28124440OMIM:231200BERNARD-SOULIER SYNDROME; BSS8
HP:0003010HP:0003010Prolonged bleeding time0GP6 CL E G H5120614388OMIM:614201Bleeding disorder, platelet-type, 11.24
HP:0003010HP:0003010Prolonged bleeding time0GP9 CL E G H28154444OMIM:231200BERNARD-SOULIER SYNDROME; BSS21
HP:0003010HP:0003010Prolonged bleeding time0HPS1 CL E G H32575163OMIM:203300Hermansky-Pudlak syndrome 1.121
HP:0003010HP:0003010Prolonged bleeding time0HPS5 CL E G H1123417022OMIM:614074Hermansky-Pudlak syndrome 5.105
HP:0003010HP:0003010Prolonged bleeding time0HPS6 CL E G H7980318817OMIM:614075Hermansky-Pudlak syndrome 6.45
HP:0003010HP:0003010Prolonged bleeding time0ITGA2B CL E G H36746138ORPHA:849Glanzmann thrombastheniaHP:0040281 - Very frequent69
HP:0003010HP:0003010Prolonged bleeding time0ITGA2B CL E G H36746138OMIM:273800Glanzmann thrombasthenia.69
HP:0003010HP:0003010Prolonged bleeding time0ITGB3 CL E G H36906156ORPHA:849Glanzmann thrombastheniaHP:0040281 - Very frequent80
HP:0003010HP:0003010Prolonged bleeding time0ITGB3 CL E G H36906156OMIM:619267GLANZMANN THROMBASTHENIA 2; GT280
HP:0003010HP:0003010Prolonged bleeding time0ITGB4 CL E G H36916158ORPHA:1114Aplasia cutis congenitaHP:0040283 - Occasional124
HP:0003010HP:0003010Prolonged bleeding time0JAK2 CL E G H37176192ORPHA:3318Essential thrombocythemiaHP:0040281 - Very frequent57
HP:0003010HP:0003010Prolonged bleeding time0MAP2K2 CL E G H56056842ORPHA:638Neurofibromatosis-Noonan syndromeHP:0040282 - Frequent178
HP:0003010HP:0003010Prolonged bleeding time0MPL CL E G H43527217ORPHA:3318Essential thrombocythemiaHP:0040281 - Very frequent97
HP:0003010HP:0003010Prolonged bleeding time0MYH9 CL E G H46277579OMIM:155100Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss.297
HP:0003010HP:0003010Prolonged bleeding time0MYH9 CL E G H46277579ORPHA:182050MYH9-related diseaseHP:0040282 - Frequent297
HP:0003010HP:0003010Prolonged bleeding time0MYRF CL E G H7451181OMIM:618280Cardiac-Urogenital syndrome2
HP:0003010HP:0003010Prolonged bleeding time0NBEAL2 CL E G H2321831928OMIM:139090Gray platelet syndrome.127
HP:0003010HP:0003010Prolonged bleeding time0NF1 CL E G H47637765ORPHA:638Neurofibromatosis-Noonan syndromeHP:0040282 - Frequent1952
HP:0003010HP:0003010Prolonged bleeding time0PLEC CL E G H53399069ORPHA:1114Aplasia cutis congenitaHP:0040283 - Occasional759
HP:0003010HP:0003010Prolonged bleeding time0RASGRP2 CL E G H102359879OMIM:615888Bleeding disorder, platelet-type, 18.11
HP:0003010HP:0003010Prolonged bleeding time0RIN2 CL E G H5445318750OMIM:613075Macs syndrome.43
HP:0003010HP:0003010Prolonged bleeding time0RUNX1 CL E G H86110471OMIM:601399Platelet disorder, familial, with associated myeloid malignancy181
HP:0003010HP:0003010Prolonged bleeding time0SH2B3 CL E G H1001929605ORPHA:3318Essential thrombocythemiaHP:0040281 - Very frequent4
HP:0003010HP:0003010Prolonged bleeding time0SLC35A1 CL E G H1055911021ORPHA:238459SLC35A1-CDGHP:0040281 - Very frequent24
HP:0003010HP:0003010Prolonged bleeding time0TEK CL E G H701011724ORPHA:1059Blue rubber bleb nevusHP:0040281 - Very frequent78
HP:0003010HP:0003010Prolonged bleeding time0TET2 CL E G H5479025941ORPHA:3318Essential thrombocythemiaHP:0040281 - Very frequent3
HP:0003010HP:0003010Prolonged bleeding time0TP53 CL E G H715711998ORPHA:3318Essential thrombocythemiaHP:0040281 - Very frequent911
HP:0003010HP:0003010Prolonged bleeding time0UBA2 CL E G H1005430661ORPHA:1114Aplasia cutis congenitaHP:0040283 - Occasional
HP:0003010HP:0003010Prolonged bleeding time0VWF CL E G H745012726OMIM:193400Von willebrand disease, type 1.533
HP:0003010HP:0003010Prolonged bleeding time0VWF CL E G H745012726OMIM:277480Von willebrand disease, type 3.533
HP:0003010HP:0003010Prolonged bleeding time0WAS CL E G H745412731ORPHA:906Wiskott-Aldrich syndromeHP:0040281 - Very frequent65
HP:0003010HP:0003010Prolonged bleeding time0WAS CL E G H745412731OMIM:301000Wiskott-Aldrich syndrome.65
HP:0003010HP:0003010Prolonged bleeding time0WIPF1 CL E G H745612736ORPHA:906Wiskott-Aldrich syndromeHP:0040281 - Very frequent6


Genes (47) :ADAMTS2 ADAMTSL2 AGGF1 AP3B1 BMS1 CALR CD36 COL1A1 COL5A1 COL5A2 CREB3L1 DLL4 F2 F5 GATA1 GATA2 GFI1B GP1BA GP1BB GP6 GP9 HPS1 HPS5 HPS6 ITGA2B ITGB3 ITGB4 JAK2 MAP2K2 MPL MYH9 MYRF NBEAL2 NF1 PLEC RASGRP2 RIN2 RUNX1 SH2B3 SLC35A1 TEK TET2 TP53 UBA2 VWF WAS WIPF1

Diseases (36) :ORPHA:1901 ORPHA:90308 OMIM:608233 ORPHA:1114 ORPHA:3318 OMIM:608404 ORPHA:287 OMIM:616229 OMIM:613679 OMIM:227400 OMIM:314050 ORPHA:3226 OMIM:187900 OMIM:231200 OMIM:177820 OMIM:614201 OMIM:203300 OMIM:614074 OMIM:614075 ORPHA:849 OMIM:273800 OMIM:619267 ORPHA:638 OMIM:155100 ORPHA:182050 OMIM:618280 OMIM:139090 OMIM:615888 OMIM:613075 OMIM:601399 ORPHA:238459 ORPHA:1059 OMIM:193400 OMIM:277480 ORPHA:906 OMIM:301000
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is December 15 2022 release.